We are live on !
Find out more
Foundry Partners Portfolio holdings
AUM
$1.89B
Turnover
15.38%
1-Year Est. Return
9.84%
This Fund
S&P 500
This Quarter Est. Return
+4.18%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.05%
10 Year Est. Return
+297.72%
AUM
$2.64B
AUM Growth
+$191M
(+7.8%)
Cap. Flow
+$124M
Cap. Flow % of AUM
Cap. Flow %
4.71%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
408
New
28
Increased
170
Reduced
184
Closed
20
Avg Time Held
2.1
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$13M |
| 2 |
CNO Financial Group
CNO
|
+$11M |
| 3 |
AGN
Allergan plc
AGN
|
+$8.97M |
| 4 |
AT&T
T
|
+$8.83M |
| 5 |
Cisco
CSCO
|
+$8.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ford
F
|
+$9.49M |
| 2 |
nVent Electric
NVT
|
+$5.99M |
| 3 |
Select Medical
SEM
|
+$5.37M |
| 4 |
O-I Glass
OI
|
+$5.23M |
| 5 |
Hillenbrand
HI
|
+$5.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.25% |
| 2 | Industrials | 15.31% |
| 3 | Technology | 12.26% |
| 4 | Healthcare | 8.81% |
| 5 | Energy | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Citigroup
C
$197B
| $44M | 1.67% |
613,708
+95,028
| +18% | +$6.72M |
2013 Q4
19 quarters
|
|
2
JPMorgan Chase
JPM
$888B
| $43.8M | 1.66% |
388,178
+59,517
| +18% | +$6.76M |
2014 Q4
15 quarters
|
|
3
Verizon
VZ
$189B
| $39.5M | 1.5% |
740,505
+115,255
| +18% | +$6.1M |
2017 Q4
3 quarters
|
|
4
BP
BP
$115B
| $37M | 1.4% |
840,642
+119,383
| +17% | +$4.99M |
2013 Q4
19 quarters
|
|
|
5
AT&T
T
$146B
| $33.5M | 1.27% |
1,320,969
+360,473
| +38% | +$8.83M |
2015 Q1
14 quarters
|
|
6
Chevron
CVX
$415B
| $31.8M | 1.21% |
259,771
+40,336
| +18% | +$4.89M |
2015 Q2
13 quarters
|
|
7
Johnson & Johnson
JNJ
$665B
| $30.6M | 1.16% |
221,659
+33,990
| +18% | +$4.52M |
2016 Q3
8 quarters
|
|
|
8
Cisco
CSCO
$370B
| $30.4M | 1.16% |
625,900
+180,115
| +40% | +$8.1M |
2017 Q2
5 quarters
|
|
9
Pfizer
PFE
$168B
| $28.2M | 1.07% |
674,599
-47,570
| -7% | -$1.83M |
2017 Q4
3 quarters
|
|
10
Capital One
COF
$121B
| $27.4M | 1.04% |
288,549
+45,294
| +19% | +$4.41M |
2014 Q2
17 quarters
|
|
11
Goldman Sachs
GS
$250B
| $26.2M | 1% |
116,948
+18,153
| +18% | +$4.22M |
2013 Q4
19 quarters
|
|
12
Fulton Financial
FULT
$4.48B
| $22.4M | 0.85% |
1,347,519
+4,223
| +0.3% | +$73.9K |
2016 Q2
9 quarters
|
|
13
Old National Bancorp
ONB
$9.43B
| $22.2M | 0.84% |
1,152,734
-205,889
| -15% | -$4.05M |
2013 Q4
19 quarters
|
|
14
CVS Health
CVS
$107B
| $22.2M | 0.84% |
281,601
+17,601
| +7% | +$1.26M |
2013 Q4
19 quarters
|
|
15
Marathon Petroleum
MPC
$101B
| $21.9M | 0.83% |
273,324
+42,200
| +18% | +$3.34M |
2013 Q4
19 quarters
|
|
16
Prudential Financial
PRU
$40.9B
| $21.5M | 0.82% |
212,394
+33,479
| +19% | +$3.3M |
2013 Q4
19 quarters
|
|
17
Hancock Whitney
HWC
$5.73B
| $21M | 0.8% |
441,432
+5,574
| +1% | +$280K |
2016 Q2
9 quarters
|
|
18
Exelon
EXC
$47.2B
| $20.4M | 0.78% |
655,790
+100,850
| +18% | +$3.1M |
2015 Q1
14 quarters
|
|
|
TCF
19
DELISTED
TCF Financial Corporation
TCF
| $20.4M | 0.77% |
856,616
+2,432
| +0.3% | +$61.7K |
2016 Q2
9 quarters
|
|
20
LyondellBasell Industries
LYB
$19.6B
| $20.3M | 0.77% |
197,706
+30,591
| +18% | +$3.35M |
2016 Q2
9 quarters
|
|
21
Target
TGT
$72B
| $20.1M | 0.76% |
227,435
+35,000
| +18% | +$2.91M |
2017 Q2
5 quarters
|
|
22
Amgen
AMGN
$249B
| $19.4M | 0.74% |
93,780
+4,825
| +5% | +$951K |
2016 Q2
9 quarters
|
|
23
Associated Banc-Corp
ASB
$5.64B
| $18.9M | 0.72% |
725,849
+2,042
| +0.3% | +$55.8K |
2016 Q2
9 quarters
|
|
24
Eaton
ETN
$133B
| $18.5M | 0.7% |
212,885
+33,420
| +19% | +$2.73M |
2016 Q2
9 quarters
|
|
|
RDS.B
25
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $18.4M | 0.7% |
259,995
+40,835
| +19% | +$2.83M |
2018 Q2
1 quarter
|
|
Similar funds
PAME
Foundry Partners's Q3 2018 Portfolio in Review
As of Q3 2018, Foundry Partners held 408 positions worth $2.64B, up 7.8% from $2.44B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Foundry Partners deployed $124M of net new capital in Q3 2018, opening 28 new positions and adding to 170 existing holdings. Its largest new stake was Caterpillar: 92,015 shares worth $14M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Select Medical, an estimated $5.37M trimmed.
- Foundry Partners's largest Q3 2018 buy was Caterpillar: 92,015 shares worth $14M.
- Foundry Partners added most to Allergan plc in Q3 2018, an estimated $8.97M increase.
- Foundry Partners's biggest Q3 2018 reduction was Select Medical, cutting an estimated $5.37M.
- Foundry Partners fully exited Ford in Q3 2018, selling an estimated $9.49M.
- Foundry Partners's ten largest holdings make up 13% of its $2.64B portfolio in Q3 2018.
- Foundry Partners opened 28 new positions and closed 20 in Q3 2018.
- Foundry Partners's portfolio value rose 7.8% quarter-over-quarter to $2.64B.
Based on Foundry Partners's 13F filing for Q3 2018, filed 17 Oct 2018.